Overview
Registration
Agenda
Faculty

Accreditation/
Credit Designation

Physicians (CME)

Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC designates this live activity for a maximum of 27.25 AMA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses (Contact Hours)

Physicians' Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669 for 27.25 Contact Hours.

Maintenance of Certification (MOC) Points

Medical Oncologists (ABIM)

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 27.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Surgical Oncologists/Surgeons

This activity provides Category I CME and self-assessment credits toward Part 2 of the ABS MOC Program. For more information, please visit www.absurgery.org

An application will be submitted to the American Board of Radiology (ABR) for SAM review.

Qualified by the American Board of Radiology on October 6, 2020 in meeting the criteria for self-assessment toward the purpose of fulfilling requirements in the ABR Maintenance of Certification Program. This activity has been qualified by the American Board of Radiology for 1.5 SAM credits.

Acknowledgment of Commercial Support

This educational activity is supported by educational grants from AstraZeneca; Daiichi Sankyo Inc.; Eisai Inc.; Lilly; MacroGenics, Inc.; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation.; Pfizer Inc; Puma Biotechnology, Inc., and Seagen Inc. (formally Seattle Genetics, Inc.)

For further information concerning Lilly grant funding, visit lillygrantoffice.com.

18th Annual School of Breast Oncology®

18th Annual School of Breast Oncology®


November 5-7, 2020

Virtual, Interactive Conference!

November 5, 2020 - 7:15 AM - 6:30 PM EST
November 6, 2020 - 7:15 AM - 6:30 PM EST
November 7, 2020 - 7:00 AM - 3:15 PM EST

Overview

An increasing number of oncologists are focusing their clinical practices on the treatment of breast cancer, creating a need for specialized education. The School of Breast Oncology®, which has been held annually since 2003, was developed to advance patient care by providing a curriculum-based program focused exclusively on breast cancer clinical management. This intensive 3-day interactive program will provide a comprehensive review of data on the most important aspects of breast cancer biology, diagnostics, prevention and treatment, with lectures emphasizing clinical implications presented by leading clinical investigators.

Acknowledgment of Commercial Support

This educational activity is supported by educational grants from AstraZeneca; Daiichi Sankyo Inc.; Eisai Inc.; Lilly; MacroGenics, Inc.; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation.; Pfizer Inc; Puma Biotechnology, Inc.; and Seagen Inc. (formally Seattle Genetics, Inc.)

For further information concerning Lilly grant funding, visit lillygrantoffice.com.

Target Audience

This educational program is directed toward medical, radiation, and surgical oncologists whose primary practice focus is breast cancer and who intend to reinforce their knowledge base and expand their expertise in breast cancer diagnosis, treatment, and management. Participants will be primarily oncologists or fellows in training whose practice requires mastery and a critical understanding of the fundamental principles, pivotal published studies, and emerging information on the pathogenesis and management of breast cancer.

Learning Objectives

  • Review breast cancer biology, staging, and prognostic and/or predictive markers, in order to better individualize therapy and counsel patients regarding conventional and investigational treatment options
  • Integrate biomarkers, molecular assays, and other risk assessment tools into treatment decision-making algorithms to optimize outcomes for patients with breast cancer
  • Discuss current and evolving imaging options for diagnosing, staging, and monitoring breast cancer
  • Incorporate current guidelines and evolving evidence on local treatment options, including new approaches in surgery and radiation therapy, into the management of patients with breast cancer
  • Individualize selection of systemic therapies for patients with early-stage or advanced/metastatic breast cancer by taking into consideration efficacy and safety, as well as patient characteristics and tumor subtype
  • Evaluate emerging clinical data and evolving strategies for the treatment of breast cancer, and apply clinical trial data appropriately in order to optimize the outcome of individual patients
  • Utilize supportive care strategies for preventing and managing treatment-related toxicities in patients receiving treatment for breast cancer
  • Facilitate awareness of clinical trial opportunities based on knowledge of emerging agents and variances in care in the field of breast cancer management

Benefits of Attending

  • Learn from experts how to integrate biomarkers, molecular assays, and other risk assessment tools into treatment decision-making algorithms to optimize outcomes for patients with breast cancer
  • Improve your knowledge about breast cancer biology, diagnosis, staging, and prognostic and/or predictive markers, in order to better select the most appropriate therapy for patients with breast cancer
  • Learn how to incorporate current guidelines and evolving evidence on local treatment options, including new approaches in surgery and radiation therapy, into the management of patients with breast cancer
  • Gain expert perspectives on individualizing the selection of systemic therapies for patients with early-stage or advanced/metastatic breast cancer by taking into consideration efficacy and safety, as well as patient characteristics and tumor subtype
  • Acquire expert insights on how to use supportive care strategies to prevent and manage treatment-related toxicities in patients receiving treatment for breast cancer

Activity Chair

Joyce O'Shaughnessy
Joyce O'Shaughnessy, MD
Celebrating Woman Chair in Breast Cancer Research
Baylor University Medical Center
Texas Oncology
Chair, Breast Cancer Research Program
The US Oncology Network
Dallas, TX

Registration

Registration fees for the School of Breast Oncology® include the following:
  • Conference e-Syllabus materials*
  • A School of Breast Oncology diploma, suitable for framing, upon successful completion of the testing
  • 24/7 access to the online testing site
* E-syllabus materials will be available electronically prior to the meeting with updates to the slides presented available on site, and registrants will receive an active link with instructions on how to access the syllabus from our website for downloading and/or printing.

2 Ways to Register
  1. Online: Click here.
  2. Phone: Please call (888) 949-0045 or (609) 378-3701 (credit cards only).
Physicians' Education Resource® - SOBO20
2 Clarke Drive, Suite 100
Cranbury, NJ 08512

Daily conference rates are now available!

We are pleased to offer flexible options to ensure viewers are able to participate in this valuable 3-day live, interactive conference. Don’t miss out on the chance to gain expert insights on breast cancer from our renowned faculty.

To attend for one day only, use code SOBO20Daily at checkout.

Registration Fees

  Virtual
Physicians $399
Fellows* $199
Nurses, PAs, Other Health Care Professionals $199
Industry** $599

 
* FELLOWS registration must be accompanied by a letter from your director/chair stating current fellowship for discount. Cannot be combined with other discounts/coupon codes.
** INDUSTRY is defined by PER® as any person employed by a for-profit organization, including biotech, financial, and pharmaceutical.
 

A cancellation fee of 25% will be assessed on refunds requested prior to October 7, 2020, and a 50% fee on refunds requested on October 8, 2020 through October 22, 2020. No refunds will be made after October 22, 2020. There is no charge for substitution. Substitutions can only be applied to the same conference and only 2 substitutions will be honored.

 
For registration assistance, please email info@gotoper.com, or call (888) 949-0045 or (609) 378-3701.

In the event of a meeting cancellation, full refunds will be processed within 30 days of the cancellation date.

Physicians' Education Resource®, LLC reserves the exclusive rights to all recordings or reproductions of the conference and supporting materials. Unauthorized recording, by any means, is expressly prohibited.  This includes, but is not limited to, recording of presentations or reproductions of supporting audio/visual materials, exhibits, and other supporting Continuing Education materials.

Meeting information is accurate at the time of posting.




Register

You must be logged in to PER to register for this meeting

Or Register for PER now

*Required Fields

Login Information


Registration Information


Professional Information


Specialties*

Submit
Calendar of Events
SUNMONTUESWEDTHURSFRISAT
    123
45678910
11121314151617
18192021222324
25262728293031
Filter By